{
  "fullName": "James P. Allison",
  "slug": "james-p-allison",
  "title": "MD",
  "specialty": "CTLA-4 Immunotherapy",
  "geography": {
    "country": "United States",
    "region": null,
    "city": null
  },
  "status": "LIVING",
  "tier": "UNRANKED",
  "rankingScore": 28,
  "hIndex": 185,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "James Patrick Allison is an American immunologist and Nobel laureate who holds the position of professor and chair of immunology and executive director of immunotherapy platform at the MD Anderson Cancer Center in Houston, Texas. Allison is Regental Professor and Founding-Director of James P. Allison Institute at the MD Anderson Cancer Center.",
  "aiSummary": "James P. Allison is a ctla-4 immunotherapy specialist with an H-index of 185 at MD Anderson Cancer Center (Faculty). Has been published in Science, Nature, Cancer Cell. Based in United States.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "MD Anderson Cancer Center",
      "role": "Faculty",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "CTLA-4 Immunotherapy"
  ],
  "knowsAbout": [],
  "citations": [
    {
      "title": "The future of immune checkpoint therapy",
      "journal": "Science",
      "year": 2015,
      "citationCount": 4666,
      "doi": "10.1126/science.aaa8172",
      "sourceUrl": "https://doi.org/10.1126/science.aaa8172",
      "verified": true
    },
    {
      "title": "Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients",
      "journal": "Science",
      "year": 2017,
      "citationCount": 4402,
      "doi": "10.1126/science.aan4236",
      "sourceUrl": "https://doi.org/10.1126/science.aan4236",
      "verified": true
    },
    {
      "title": "Restoring function in exhausted CD8 T cells during chronic viral infection",
      "journal": "Nature",
      "year": 2005,
      "citationCount": 3908,
      "doi": "10.1038/nature04444",
      "sourceUrl": "https://doi.org/10.1038/nature04444",
      "verified": true
    },
    {
      "title": "Enhancement of Antitumor Immunity by CTLA-4 Blockade",
      "journal": "Science",
      "year": 1996,
      "citationCount": 3848,
      "doi": "10.1126/science.271.5256.1734",
      "sourceUrl": "https://doi.org/10.1126/science.271.5256.1734",
      "verified": true
    },
    {
      "title": "Fundamental Mechanisms of Immune Checkpoint Blockade Therapy",
      "journal": "Cancer Discovery",
      "year": 2018,
      "citationCount": 2964,
      "doi": "10.1158/2159-8290.cd-18-0367",
      "sourceUrl": "https://doi.org/10.1158/2159-8290.cd-18-0367",
      "verified": true
    },
    {
      "title": "Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival",
      "journal": "Cancer Cell",
      "year": 2014,
      "citationCount": 2495,
      "doi": "10.1016/j.ccr.2014.04.005",
      "sourceUrl": "https://doi.org/10.1016/j.ccr.2014.04.005",
      "verified": true
    },
    {
      "title": "Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential",
      "journal": "Cell",
      "year": 2015,
      "citationCount": 2286,
      "doi": "10.1016/j.cell.2015.03.030",
      "sourceUrl": "https://doi.org/10.1016/j.cell.2015.03.030",
      "verified": true
    },
    {
      "title": "CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.",
      "journal": "The Journal of Experimental Medicine",
      "year": 1995,
      "citationCount": 2173,
      "doi": "10.1084/jem.182.2.459",
      "sourceUrl": "https://doi.org/10.1084/jem.182.2.459",
      "verified": true
    },
    {
      "title": "Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma",
      "journal": "New England Journal of Medicine",
      "year": 2012,
      "citationCount": 2033,
      "doi": "10.1056/nejmoa1112824",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1112824",
      "verified": true
    },
    {
      "title": "Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens",
      "journal": "Nature",
      "year": 2014,
      "citationCount": 1956,
      "doi": "10.1038/nature13988",
      "sourceUrl": "https://doi.org/10.1038/nature13988",
      "verified": true
    },
    {
      "title": "PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors",
      "journal": "Proceedings of the National Academy of Sciences",
      "year": 2010,
      "citationCount": 1846,
      "doi": "10.1073/pnas.0915174107",
      "sourceUrl": "https://doi.org/10.1073/pnas.0915174107",
      "verified": true
    },
    {
      "title": "Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma",
      "journal": "Proceedings of the National Academy of Sciences",
      "year": 2003,
      "citationCount": 1566,
      "doi": "10.1073/pnas.1533209100",
      "sourceUrl": "https://doi.org/10.1073/pnas.1533209100",
      "verified": true
    },
    {
      "title": "CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones",
      "journal": "Nature",
      "year": 1992,
      "citationCount": 1547,
      "doi": "10.1038/356607a0",
      "sourceUrl": "https://doi.org/10.1038/356607a0",
      "verified": true
    },
    {
      "title": "Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma",
      "journal": "The Journal of Experimental Medicine",
      "year": 2013,
      "citationCount": 1421,
      "doi": "10.1084/jem.20130579",
      "sourceUrl": "https://doi.org/10.1084/jem.20130579",
      "verified": true
    },
    {
      "title": "The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research",
      "journal": "Clinical Cancer Research",
      "year": 2009,
      "citationCount": 1353,
      "doi": "10.1158/1078-0432.ccr-09-0737",
      "sourceUrl": "https://doi.org/10.1158/1078-0432.ccr-09-0737",
      "verified": true
    },
    {
      "title": "Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting",
      "journal": "Nature",
      "year": 2012,
      "citationCount": 1259,
      "doi": "10.1038/nature10755",
      "sourceUrl": "https://doi.org/10.1038/nature10755",
      "verified": true
    },
    {
      "title": "Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy",
      "journal": "Cell",
      "year": 2016,
      "citationCount": 1257,
      "doi": "10.1016/j.cell.2016.08.069",
      "sourceUrl": "https://doi.org/10.1016/j.cell.2016.08.069",
      "verified": true
    },
    {
      "title": "Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade",
      "journal": "Cell",
      "year": 2017,
      "citationCount": 1222,
      "doi": "10.1016/j.cell.2017.07.024",
      "sourceUrl": "https://doi.org/10.1016/j.cell.2017.07.024",
      "verified": true
    },
    {
      "title": "Tumor Rejection After Direct Costimulation of CD8 <sup>+</sup> T Cells by B7-Transfected Melanoma Cells",
      "journal": "Science",
      "year": 1993,
      "citationCount": 1142,
      "doi": "10.1126/science.7678351",
      "sourceUrl": "https://doi.org/10.1126/science.7678351",
      "verified": true
    },
    {
      "title": "Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity",
      "journal": "Nature Communications",
      "year": 2016,
      "citationCount": 1074,
      "doi": "10.1038/ncomms12632",
      "sourceUrl": "https://doi.org/10.1038/ncomms12632",
      "verified": true
    },
    {
      "title": "Combination Immunotherapy of B16 Melanoma Using Anti–Cytotoxic T Lymphocyte–Associated Antigen 4 (Ctla-4) and Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf)-Producing Vaccines Induces Rejection of Subcutaneous and Metastatic Tumors Accompanied by Autoimmune Depigmentation",
      "journal": "The Journal of Experimental Medicine",
      "year": 1999,
      "citationCount": 1011,
      "doi": "10.1084/jem.190.3.355",
      "sourceUrl": "https://doi.org/10.1084/jem.190.3.355",
      "verified": true
    },
    {
      "title": "Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses",
      "journal": "The Journal of Experimental Medicine",
      "year": 2001,
      "citationCount": 1011,
      "doi": "10.1084/jem.194.6.823",
      "sourceUrl": "https://doi.org/10.1084/jem.194.6.823",
      "verified": true
    },
    {
      "title": "Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients",
      "journal": "Proceedings of the National Academy of Sciences",
      "year": 2003,
      "citationCount": 991,
      "doi": "10.1073/pnas.0830997100",
      "sourceUrl": "https://doi.org/10.1073/pnas.0830997100",
      "verified": true
    },
    {
      "title": "Immune-Mediated Inhibition of Metastases after Treatment with Local Radiation and CTLA-4 Blockade in a Mouse Model of Breast Cancer",
      "journal": "Clinical Cancer Research",
      "year": 2005,
      "citationCount": 990,
      "doi": "10.1158/1078-0432.728.11.2",
      "sourceUrl": "https://doi.org/10.1158/1078-0432.728.11.2",
      "verified": true
    },
    {
      "title": "CTLA-4-Mediated Inhibition in Regulation of T Cell Responses: Mechanisms and Manipulation in Tumor Immunotherapy",
      "journal": "Annual Review of Immunology",
      "year": 2001,
      "citationCount": 984,
      "doi": "10.1146/annurev.immunol.19.1.565",
      "sourceUrl": "https://doi.org/10.1146/annurev.immunol.19.1.565",
      "verified": true
    },
    {
      "title": "Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade",
      "journal": "Cancer Discovery",
      "year": 2016,
      "citationCount": 971,
      "doi": "10.1158/2159-8290.cd-15-1545",
      "sourceUrl": "https://doi.org/10.1158/2159-8290.cd-15-1545",
      "verified": true
    },
    {
      "title": "Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis",
      "journal": "Nature Medicine",
      "year": 2015,
      "citationCount": 940,
      "doi": "10.1038/nm.3902",
      "sourceUrl": "https://doi.org/10.1038/nm.3902",
      "verified": true
    },
    {
      "title": "Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies",
      "journal": "The Journal of Experimental Medicine",
      "year": 2009,
      "citationCount": 937,
      "doi": "10.1084/jem.20082492",
      "sourceUrl": "https://doi.org/10.1084/jem.20082492",
      "verified": true
    },
    {
      "title": "ICOS co-stimulatory receptor is essential for T-cell activation and function",
      "journal": "Nature",
      "year": 2001,
      "citationCount": 928,
      "doi": "10.1038/35051100",
      "sourceUrl": "https://doi.org/10.1038/35051100",
      "verified": true
    },
    {
      "title": "CTLA-4: new insights into its biological function and use in tumor immunotherapy",
      "journal": "Nature Immunology",
      "year": 2002,
      "citationCount": 927,
      "doi": "10.1038/ni0702-611",
      "sourceUrl": "https://doi.org/10.1038/ni0702-611",
      "verified": true
    },
    {
      "title": "CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells.",
      "journal": "The Journal of Experimental Medicine",
      "year": 1996,
      "citationCount": 918,
      "doi": "10.1084/jem.183.6.2533",
      "sourceUrl": "https://doi.org/10.1084/jem.183.6.2533",
      "verified": true
    },
    {
      "title": "Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance",
      "journal": "Science Translational Medicine",
      "year": 2017,
      "citationCount": 899,
      "doi": "10.1126/scitranslmed.aah3560",
      "sourceUrl": "https://doi.org/10.1126/scitranslmed.aah3560",
      "verified": true
    },
    {
      "title": "Immune checkpoint therapy—current perspectives and future directions",
      "journal": "Cell",
      "year": 2023,
      "citationCount": 884,
      "doi": "10.1016/j.cell.2023.03.006",
      "sourceUrl": "https://doi.org/10.1016/j.cell.2023.03.006",
      "verified": true
    },
    {
      "title": "Co-occurring Genomic Alterations Define Major Subsets of <i>KRAS</i> -Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities",
      "journal": "Cancer Discovery",
      "year": 2015,
      "citationCount": 878,
      "doi": "10.1158/2159-8290.cd-14-1236",
      "sourceUrl": "https://doi.org/10.1158/2159-8290.cd-14-1236",
      "verified": true
    },
    {
      "title": "BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1",
      "journal": "Nature Immunology",
      "year": 2003,
      "citationCount": 863,
      "doi": "10.1038/ni944",
      "sourceUrl": "https://doi.org/10.1038/ni944",
      "verified": true
    },
    {
      "title": "Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts",
      "journal": "The Journal of Experimental Medicine",
      "year": 2010,
      "citationCount": 857,
      "doi": "10.1084/jem.20091918",
      "sourceUrl": "https://doi.org/10.1084/jem.20091918",
      "verified": true
    },
    {
      "title": "Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response",
      "journal": "Science",
      "year": 2021,
      "citationCount": 799,
      "doi": "10.1126/science.aaz7015",
      "sourceUrl": "https://doi.org/10.1126/science.aaz7015",
      "verified": true
    },
    {
      "title": "Cancer classification using the Immunoscore: a worldwide task force",
      "journal": "Journal of Translational Medicine",
      "year": 2012,
      "citationCount": 798,
      "doi": "10.1186/1479-5876-10-205",
      "sourceUrl": "https://doi.org/10.1186/1479-5876-10-205",
      "verified": true
    },
    {
      "title": "Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma",
      "journal": "Nature Medicine",
      "year": 2018,
      "citationCount": 797,
      "doi": "10.1038/s41591-018-0197-1",
      "sourceUrl": "https://doi.org/10.1038/s41591-018-0197-1",
      "verified": true
    },
    {
      "title": "The Next Decade of Immune Checkpoint Therapy",
      "journal": "Cancer Discovery",
      "year": 2021,
      "citationCount": 716,
      "doi": "10.1158/2159-8290.cd-20-1680",
      "sourceUrl": "https://doi.org/10.1158/2159-8290.cd-20-1680",
      "verified": true
    },
    {
      "title": "Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy",
      "journal": "Science Translational Medicine",
      "year": 2014,
      "citationCount": 690,
      "doi": "10.1126/scitranslmed.3008095",
      "sourceUrl": "https://doi.org/10.1126/scitranslmed.3008095",
      "verified": true
    },
    {
      "title": "Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis",
      "journal": "Nature Medicine",
      "year": 2018,
      "citationCount": 689,
      "doi": "10.1038/s41591-018-0238-9",
      "sourceUrl": "https://doi.org/10.1038/s41591-018-0238-9",
      "verified": true
    },
    {
      "title": "Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients",
      "journal": "Proceedings of the National Academy of Sciences",
      "year": 2008,
      "citationCount": 649,
      "doi": "10.1073/pnas.0712237105",
      "sourceUrl": "https://doi.org/10.1073/pnas.0712237105",
      "verified": true
    },
    {
      "title": "Novel cancer immunotherapy agents with survival benefit: recent successes and next steps",
      "journal": "Nature reviews. Cancer",
      "year": 2011,
      "citationCount": 633,
      "doi": "10.1038/nrc3153",
      "sourceUrl": "https://doi.org/10.1038/nrc3153",
      "verified": true
    },
    {
      "title": "Mechanisms of Resistance to Immune Checkpoint Blockade: Why Does Checkpoint Inhibitor Immunotherapy Not Work for All Patients?",
      "journal": "American Society of Clinical Oncology Educational Book",
      "year": 2019,
      "citationCount": 630,
      "doi": "10.1200/edbk_240837",
      "sourceUrl": "https://doi.org/10.1200/edbk_240837",
      "verified": true
    },
    {
      "title": "The Emerging Role of CTLA-4 as an Immune Attenuator",
      "journal": "Immunity",
      "year": 1997,
      "citationCount": 627,
      "doi": "10.1016/s1074-7613(00)80366-0",
      "sourceUrl": "https://doi.org/10.1016/s1074-7613(00)80366-0",
      "verified": true
    },
    {
      "title": "Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4",
      "journal": "The Journal of Experimental Medicine",
      "year": 2013,
      "citationCount": 625,
      "doi": "10.1084/jem.20130066",
      "sourceUrl": "https://doi.org/10.1084/jem.20130066",
      "verified": true
    },
    {
      "title": "Constitutive class I-restricted exogenous presentation of self antigens in vivo.",
      "journal": "The Journal of Experimental Medicine",
      "year": 1996,
      "citationCount": 620,
      "doi": "10.1084/jem.184.3.923",
      "sourceUrl": "https://doi.org/10.1084/jem.184.3.923",
      "verified": true
    },
    {
      "title": "Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer",
      "journal": "Nature Communications",
      "year": 2017,
      "citationCount": 611,
      "doi": "10.1038/ncomms15095",
      "sourceUrl": "https://doi.org/10.1038/ncomms15095",
      "verified": true
    },
    {
      "title": "PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells",
      "journal": "Proceedings of the National Academy of Sciences",
      "year": 2003,
      "citationCount": 610,
      "doi": "10.1073/pnas.0931259100",
      "sourceUrl": "https://doi.org/10.1073/pnas.0931259100",
      "verified": true
    }
  ],
  "awards": [],
  "timeline": [],
  "subSpecialty": null,
  "lastFixedAt": "2026-02-16T05:45:14.000Z",
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/thumb/f/ff/James_P._Allison_EM1B5525_%2846207775441%29.jpg/330px-James_P._Allison_EM1B5525_%2846207775441%29.jpg",
  "openalexId": "https://openalex.org/A5047117233"
}